{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:56:02Z","timestamp":1772859362599,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10072-020-04880-x","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T05:26:14Z","timestamp":1606195574000},"page":"407-413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Down\u2019s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-4953","authenticated-orcid":false,"given":"Marcos","family":"Altable","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Mois\u00e9s","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"4880_CR1","doi-asserted-by":"publisher","unstructured":"Kumar M, Thakur AK (2020) Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04823-6","DOI":"10.1007\/s10072-020-04823-6"},{"key":"4880_CR2","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s10072-020-04695-w","volume":"41","author":"S Sultana","year":"2020","unstructured":"Sultana S, Ananthapur V (2020)COVID-19 and its impact on neurological manifestations and mental health: the present scenario. Neurol Sci 41:3015\u20133020. https:\/\/doi.org\/10.1007\/s10072-020-04695-w","journal-title":"Neurol Sci"},{"key":"4880_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fpsyt.2017.00148","volume":"8","author":"D De Berardis","year":"2017","unstructured":"De Berardis D, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F et al (2017) Alexithymia and suicide risk in psychiatric disorders: a mini-review. Front Psychiatry 8:148. https:\/\/doi.org\/10.3389\/fpsyt.2017.00148","journal-title":"Front Psychiatry"},{"key":"4880_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000325170","volume":"45","author":"F Leweke","year":"2011","unstructured":"Leweke F, Leichsenring F, Kruse J, Hermes S (2011) Is alexithymia associated with specific mental disorders? Psychopathology 45:22\u201328. https:\/\/doi.org\/10.1159\/000325170","journal-title":"Psychopathology"},{"key":"4880_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.psychres.2015.12.022","volume":"236","author":"B Engel-Yeger","year":"2016","unstructured":"Engel-Yeger B, Muzio C, Rinosi G, Solano P, Geoffroy PA, Pompili M, Amore M, Serafini G (2016) Extreme sensory processing patterns and their relation with clinical conditions among individuals with major affective disorders. Psychiatry Res 236:112\u2013118. https:\/\/doi.org\/10.1016\/j.psychres.2015.12.022","journal-title":"Psychiatry Res"},{"key":"4880_CR6","doi-asserted-by":"crossref","unstructured":"Langdon-Down JLH. On some of the mental affections of childhood and youth being The Lettsomian Lectures delivered before The Medical Society of London in 1887 together with other papers. Ment Affect Child Youth Being Lettsomian Lect Deliv before Med Soc London 1887 Together with Other Pap 1990:1\u201384","DOI":"10.1136\/bmj.1.1360.149"},{"key":"4880_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","volume":"15","author":"C Ballard","year":"2016","unstructured":"Ballard C, Mobley W, Hardy J, Williams G, Corbett A (2016) Dementia in Down\u2019s syndrome. Lancet Neurol 15:622\u2013636. https:\/\/doi.org\/10.1016\/S1474-4422(16)00063-6","journal-title":"Lancet Neurol"},{"key":"4880_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1590\/S1516-44462000000200011","volume":"22","author":"L Moreira","year":"2000","unstructured":"Moreira L, El-Hani CN, Gusm\u00e3o FAF (2000) A s\u00edndrome de Down e sua patog\u00eanese: considera\u00e7\u00f5es sobre o determinismo gen\u00e9tico. Braz J Psychiatry 22:96\u201399","journal-title":"Braz J Psychiatry"},{"key":"4880_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P","volume":"6","author":"RS Chapman","year":"2000","unstructured":"Chapman RS, Hesketh LJ (2000) Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev 6:84\u201395","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"4880_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2012.94","volume":"21","author":"M Loane","year":"2013","unstructured":"Loane M, Morris JK, Addor MC, Arriola L, Budd J, Doray B, Garne E, Gatt M, Haeusler M, Khoshnood B, Klungs\u00f8yr Melve K, Latos-Bielenska A, McDonnell B, Mullaney C, O\u2019Mahony M, Quei\u00dfer-Wahrendorf A, Rankin J, Rissmann A, Rounding C, Salvador J, Tucker D, Wellesley D, Yevtushok L, Dolk H (2013)Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 21:27\u201333. https:\/\/doi.org\/10.1038\/ejhg.2012.94","journal-title":"Eur J Hum Genet"},{"key":"4880_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","volume":"163","author":"AP Presson","year":"2013","unstructured":"Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL et al (2013) Current estimate of Down syndrome population prevalence in the United States. J Pediatr 163:1163\u20131168","journal-title":"J Pediatr"},{"key":"4880_CR12","unstructured":"FAQ and facts about down syndrome-Global Down Syndrome Foundation n.d. https:\/\/www.globaldownsyndrome.org\/about-down-syndrome\/facts-about-down-syndrome\/ (accessed 12 July 2020)"},{"key":"4880_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","volume":"9","author":"IT Lott","year":"2010","unstructured":"Lott IT, Dierssen M (2010) Cognitive deficits and associated neurological complications in individuals with Down\u2019s syndrome. Lancet Neurol 9:623\u2013633. https:\/\/doi.org\/10.1016\/S1474-4422(10)70112-5","journal-title":"Lancet Neurol"},{"key":"4880_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2788.2004.00478.x","volume":"48","author":"S Vicari","year":"2004","unstructured":"Vicari S, Marotta L, Carlesimo GA (2004) Verbal short-term memory in Down\u2019s syndrome: an articulatory loop deficit? J Intellect Disabil Res 48:80\u201392. https:\/\/doi.org\/10.1111\/j.1365-2788.2004.00478.x","journal-title":"J Intellect Disabil Res"},{"key":"4880_CR15","doi-asserted-by":"publisher","unstructured":"Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. Down syndrome: an insight of the disease. J Biomed Sci 2015;22. https:\/\/doi.org\/10.1186\/s12929-015-0138-y, 22","DOI":"10.1186\/s12929-015-0138-y"},{"key":"4880_CR16","first-page":"6","volume":"7","author":"G Holmes","year":"2014","unstructured":"Holmes G (2014) Gastrointestinal disorders in Down syndrome. Gastroenterol Hepatol Bed Bench 7:6","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"4880_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.23750\/abm.v89i1.7120","volume":"89","author":"NH Amr","year":"2018","unstructured":"Amr NH (2018) Thyroid disorders in subjects with down syndrome: an update. Acta Biomed 89:132\u2013139. https:\/\/doi.org\/10.23750\/abm.v89i1.7120","journal-title":"Acta Biomed"},{"key":"4880_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pai.13133","volume":"31","author":"RHJ Verstegen","year":"2020","unstructured":"Verstegen RHJ, Chang KJJ, Kusters MAA (2020) Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatr Allergy Immunol 31:117\u2013123. https:\/\/doi.org\/10.1111\/pai.13133","journal-title":"Pediatr Allergy Immunol"},{"key":"4880_CR19","first-page":"55","volume":"1","author":"K Matuszak","year":"2010","unstructured":"Matuszak K, Bryl W, Pupek-Musialik D (2010) Obesity in children and adolescents with mental retardation. Forum Zab Metab 1:55\u201363","journal-title":"Forum Zab Metab"},{"key":"4880_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1515\/RNS.2011.037","volume":"22","author":"R Bartesaghi","year":"2011","unstructured":"Bartesaghi R, Guide S, Ciani E (2011) Is it possible to improve neurodevelopmental abnormalities in Down syndrome? Rev Neurosci 22:419\u2013455. https:\/\/doi.org\/10.1515\/RNS.2011.037","journal-title":"Rev Neurosci"},{"key":"4880_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/brain\/awh101","volume":"127","author":"SJ Teipel","year":"2004","unstructured":"Teipel SJ, Alexander GE, Schapiro MB, M\u00f6ller H-J, Rapoport SI, Hampel H (2004)Age-related cortical grey matter reductions in non-demented Down\u2019s syndrome adults determined by MRI with voxel-based morphometry. Brain 127:811\u2013824","journal-title":"Brain"},{"key":"4880_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11682-014-9290-3","volume":"8","author":"O \u0160veljo","year":"2014","unstructured":"\u0160veljo O, \u0106uli\u0107 M, Kopriv\u0161ek K, Lu\u010di\u0107 M (2014) The functional neuroimaging evidence of cerebellar involvement in the simple cognitive task. Brain Imaging Behav 8:480\u2013486. https:\/\/doi.org\/10.1007\/s11682-014-9290-3","journal-title":"Brain Imaging Behav"},{"key":"4880_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","volume":"16","author":"FK Wiseman","year":"2015","unstructured":"Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VLJ et al (2015) A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci 16:564\u2013574","journal-title":"Nat Rev Neurosci"},{"key":"4880_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(11)61676-0","volume":"379","author":"M Hanney","year":"2012","unstructured":"Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C (2012) Memantine for dementia in adults older than 40 years with Down\u2019s syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet 379:528\u2013536. https:\/\/doi.org\/10.1016\/S0140-6736(11)61676-0","journal-title":"Lancet"},{"key":"4880_CR25","doi-asserted-by":"publisher","first-page":"104772","DOI":"10.1016\/j.nbd.2020.104772","volume":"137","author":"A Tramutola","year":"2020","unstructured":"Tramutola A, Lanzillotta C, Di Domenico F, Head E, Butterfield DA, Perluigi M et al (2020) Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiol Dis 137:104772. https:\/\/doi.org\/10.1016\/j.nbd.2020.104772","journal-title":"Neurobiol Dis"},{"key":"4880_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fnins.2018.00830","volume":"12","author":"LSS Ferreira","year":"2018","unstructured":"Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018) Insulin resistance in Alzheimer\u2019s disease. Front Neurosci 12:830","journal-title":"Front Neurosci"},{"key":"4880_CR27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, de Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated A\u03b2 oligomers. J Clin Invest 122:1339\u20131353. https:\/\/doi.org\/10.1172\/JCI57256","journal-title":"J Clin Invest"},{"key":"4880_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Esp\u00edrito-Santo S, Campello-Costa P, Houzel JC, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, de Felice FG (2013)TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys. Cell Metab 18:831\u2013843. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.002","journal-title":"Cell Metab"},{"key":"4880_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbi.2018.10.004","volume":"75","author":"T Illouz","year":"2019","unstructured":"Illouz T, Madar R, Biragyn A, Okun E (2019) Restoring microglial and astroglial homeostasis using DNA immunization in a Down syndrome mouse model. Brain Behav Immun 75:163\u2013180. https:\/\/doi.org\/10.1016\/j.bbi.2018.10.004","journal-title":"Brain Behav Immun"},{"key":"4880_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10072-016-2554-5","volume":"37","author":"M Salemi","year":"2016","unstructured":"Salemi M, Barone C, Morale MC, Caniglia S, Romano C, Salluzzo MG, Rando RGG, Ragalmuto A, Bosco P, Romano C (2016)Killer-specific secretory (Ksp37) gene expression in subjects with Down\u2019s syndrome. Neurol Sci 37:793\u2013795. https:\/\/doi.org\/10.1007\/s10072-016-2554-5","journal-title":"Neurol Sci"},{"key":"4880_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20040544","volume":"382","author":"S Beinke","year":"2004","unstructured":"Beinke S, Ley SC (2004) Functions of NF-\u03baB1 and NF-\u03baB2 in immune cell biology. Biochem J 382:393\u2013409. https:\/\/doi.org\/10.1042\/BJ20040544","journal-title":"Biochem J"},{"key":"4880_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10072-014-1981-4","volume":"36","author":"M Salemi","year":"2015","unstructured":"Salemi M, Barone C, Romano C, Scillato F, Ragalmuto A, Caniglia S, Salluzzo MG, Sciuto G, Ridolfo F, Romano C, Bosco P (2015)NF-kB1 gene expression in Down syndrome patients. Neurol Sci 36:1065\u20131066. https:\/\/doi.org\/10.1007\/s10072-014-1981-4","journal-title":"Neurol Sci"},{"key":"4880_CR33","unstructured":"WHO | World Health Organization n.d. https:\/\/www.who.int\/ (accessed 13 July 2020)"},{"key":"4880_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/256294","volume":"2012","author":"C Tikellis","year":"2012","unstructured":"Tikellis C, Thomas MC (2012)Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:1\u20138","journal-title":"Int J Pept"},{"key":"4880_CR35","unstructured":"Ministerio de Sanidad, Consumo y Bienestar Social - Profesionales - Informaci\u00f3n cient\u00edfico-t\u00e9cnica, enfermedad por coronavirus, COVID-19 n.d. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/ITCoronavirus\/home.htm (accessed 13 July 2020)"},{"key":"4880_CR36","unstructured":"Johns Hopkins CSSE. Coronavirus COVID-19(2019-nCoV) 2020. https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6 (accessed 7 Mar 2020)"},{"key":"4880_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/00004583-199211000-00013","volume":"31","author":"NL Hornstein","year":"1992","unstructured":"Hornstein NL, Putnam FW (1992) Clinical phenomenology of child and adolescent dissociative disorders. J Am Acad Child Adolesc Psychiatry 31:1077\u20131085. https:\/\/doi.org\/10.1097\/00004583-199211000-00013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4880_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cjca.2020.05.018","volume":"36","author":"M Boukhris","year":"2020","unstructured":"Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L (2020) Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol 36:1068\u20131080. https:\/\/doi.org\/10.1016\/j.cjca.2020.05.018","journal-title":"Can J Cardiol"},{"key":"4880_CR39","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.bbih.2020.100092","volume":"6","author":"M Altable","year":"2020","unstructured":"Altable M, de la Serna JM (2020) Cerebrovascular disease in COVID-19: is there a higher risk of stroke? Brain Behav Immun Health 6:100092. https:\/\/doi.org\/10.1016\/j.bbih.2020.100092","journal-title":"Brain Behav Immun Health"},{"key":"4880_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"4880_CR41","doi-asserted-by":"publisher","unstructured":"Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y et al (2020) Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.12.945576","DOI":"10.1101\/2020.02.12.945576"},{"key":"4880_CR42","first-page":"1","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa AL, Gallenga CE, Ross R, Frydas I et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34:1","journal-title":"J Biol Regul Homeost Agents"},{"key":"4880_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","volume":"6","author":"A Shimabukuro-Vornhagen","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, Stemmler HJ, Schl\u00f6\u00dfer HA, Schlaak M, Kochanek M, B\u00f6ll B, von Bergwelt-Baildon MS (2018) Cytokine release syndrome. J Immunother Cancer 6:56. https:\/\/doi.org\/10.1186\/s40425-018-0343-9","journal-title":"J Immunother Cancer"},{"key":"4880_CR44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"4880_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124:188\u2013195. https:\/\/doi.org\/10.1182\/blood-2014-05-552729","journal-title":"Blood"},{"key":"4880_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3760\/cma.j.issn.0253-2727.2020.0002","volume":"41","author":"H Mei","year":"2020","unstructured":"Mei H, Hu Y (2020) Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19. Zhonghua Xue Ye Xue Za Zhi 41:185\u2013191. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2020.0002","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"4880_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1744-313X.2010.00914.x","volume":"37","author":"S Cetiner","year":"2010","unstructured":"Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y (2010) Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 37:233\u2013237. https:\/\/doi.org\/10.1111\/j.1744-313X.2010.00914.x","journal-title":"Int J Immunogenet"},{"key":"4880_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbi.2018.05.008","volume":"73","author":"N Rueda","year":"2018","unstructured":"Rueda N, Vidal V, Garc\u00eda-Cerro S, Narc\u00eds JO, Llorens-Mart\u00edn M, Corrales A, Lantigua S, Iglesias M, Merino J, Merino R, Mart\u00ednez-Cu\u00e9 C (2018)Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice. Brain Behav Immun 73:235\u2013251. https:\/\/doi.org\/10.1016\/j.bbi.2018.05.008","journal-title":"Brain Behav Immun"},{"key":"4880_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00005176-199304000-00007","volume":"16","author":"M Castro","year":"1993","unstructured":"Castro M, Crin\u00f2 A, Papadatou B, Purpura M, Giannotti A, Ferretti F, Colistro F, Mottola L, Digilio MC, Lucidi V, Borrelli P (1993) Down\u2019s syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21. J Pediatr Gastroenterol Nutr 16:265\u2013268","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4880_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2788.1993.tb00324.x","volume":"37","author":"L NESPOLI","year":"1993","unstructured":"NESPOLI L, BURGIO GR, UGAZIO AG, MACCARIO R (1993) Immunological features of Down\u2019s syndrome: a review. J Intellect Disabil Res 37:543\u2013551. https:\/\/doi.org\/10.1111\/j.1365-2788.1993.tb00324.x","journal-title":"J Intellect Disabil Res"},{"key":"4880_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1203\/00006450-199808000-00019","volume":"44","author":"I Scotese","year":"1998","unstructured":"Scotese I, Gaetaniello L, Matarese G, Lecora M, Racioppi L, Pignata C (1998) T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down\u2019s syndrome. Pediatr Res 44:252\u2013258. https:\/\/doi.org\/10.1203\/00006450-199808000-00019","journal-title":"Pediatr Res"},{"key":"4880_CR52","doi-asserted-by":"publisher","first-page":"e20180225","DOI":"10.1542\/peds.2018-0225","volume":"142","author":"AA Beckhaus","year":"2018","unstructured":"Beckhaus AA, Castro-Rodriguez JA (2018) Down syndrome and the risk of severe RSV infection: a meta-analysis. Pediatrics 142:e20180225. https:\/\/doi.org\/10.1542\/peds.2018-0225","journal-title":"Pediatrics"},{"key":"4880_CR53","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3201\/eid1608.091931","volume":"16","author":"R P\u00e9rez-Padilla","year":"2010","unstructured":"P\u00e9rez-Padilla R, Fern\u00e1ndez R, Garc\u00eda-Sancho C, Franco-Marina F, Aburto O, L\u00f3pez-Gatell H, Boj\u00f3rquez I (2010) Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis 16:1312\u20131314. https:\/\/doi.org\/10.3201\/eid1608.091931","journal-title":"Emerg Infect Dis"},{"key":"4880_CR54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpeds.2020.06.076","volume":"225","author":"US Krishnan","year":"2020","unstructured":"Krishnan US, Krishnan SS, Jain S, Chavolla-Calderon MB, Lewis M, Chung WK, Rosenzweig EB (2020)SARS-CoV-2 infection in patients with Down syndrome, congenital heart disease, and pulmonary hypertension: is Down syndrome a risk factor? J Pediatr 225:246\u2013248. https:\/\/doi.org\/10.1016\/j.jpeds.2020.06.076","journal-title":"J Pediatr"},{"key":"4880_CR55","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","volume":"1","author":"JM Espinosa","year":"2020","unstructured":"Espinosa JM (2020) Down syndrome and COVID-19: a perfect storm? Cell Rep Med 1:100019. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100019","journal-title":"Cell Rep Med"},{"key":"4880_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/icb.2012.9","volume":"90","author":"NA De Weerd","year":"2012","unstructured":"De Weerd NA, Nguyen T (2012) The interferons and their receptors-distribution and regulation. Immunol Cell Biol 90:483\u2013491. https:\/\/doi.org\/10.1038\/icb.2012.9","journal-title":"Immunol Cell Biol"},{"key":"4880_CR57","first-page":"493","volume":"11","author":"ZP Duan","year":"2003","unstructured":"Duan ZP, Chen Y, Zhang J, Zhao J, Lang ZW, Meng FK et al (2003) Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome. Zhonghua Gan Zang Bing Za Zhi= Zhonghua Ganzangbing Zazhi= Chin J Hepatol 11:493","journal-title":"Zhonghua Gan Zang Bing Za Zhi= Zhonghua Ganzangbing Zazhi= Chin J Hepatol"},{"key":"4880_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10875-020-00805-7","volume":"40","author":"RHJ Verstegen","year":"2020","unstructured":"Verstegen RHJ, Kusters MAA (2020) Inborn errors of adaptive immunity in Down syndrome. J Clin Immunol 40:791\u2013806. https:\/\/doi.org\/10.1007\/s10875-020-00805-7","journal-title":"J Clin Immunol"},{"key":"4880_CR59","doi-asserted-by":"publisher","unstructured":"Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, Smith KP, Liggett LA, Gomez EB, Galbraith MD, DeGregori J, Espinosa JM (2016) Trisomy 21 consistently activates the interferon response. Elife 5. https:\/\/doi.org\/10.7554\/eLife.16220","DOI":"10.7554\/eLife.16220"},{"key":"4880_CR60","unstructured":"Cytokine storm and the H5N1 influenza pandemic: the bird flu n.d. http:\/\/www.cytokinestorm.com\/ (accessed 13 July 2020)"},{"key":"4880_CR61","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","volume":"18","author":"H Hasle","year":"2016","unstructured":"Hasle H, Friedman JM, Olsen JH, Rasmussen SA (2016) Low risk of solid tumors in persons with Down syndrome. Genet Med 18:1151\u20131157. https:\/\/doi.org\/10.1038\/gim.2016.23","journal-title":"Genet Med"},{"key":"4880_CR62","doi-asserted-by":"publisher","unstructured":"Satg\u00e9 D, Seidel MG (2018) The pattern of malignancies in down syndrome and its potential context with the immune system. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.03058","DOI":"10.3389\/fimmu.2018.03058"},{"key":"4880_CR63","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/geno.2000.6127","volume":"64","author":"P Strippoli","year":"2000","unstructured":"Strippoli P, Lenzi L, Petrini M, Carinci P, Zannotti M (2000) A new gene family including DSCR1 (Down syndrome candidate region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). Genomics 64:252\u2013263. https:\/\/doi.org\/10.1006\/geno.2000.6127","journal-title":"Genomics"},{"key":"4880_CR64","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","volume":"163","author":"AM Liddicoat","year":"2019","unstructured":"Liddicoat AM, Lavelle EC (2019) Modulation of innate immunity by cyclosporine A. Biochem Pharmacol 163:472\u2013480. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.022","journal-title":"Biochem Pharmacol"},{"key":"4880_CR65","doi-asserted-by":"publisher","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","volume":"7","author":"S Pfefferle","year":"2011","unstructured":"Pfefferle S, Sch\u00f6pf J, K\u00f6gl M, Friedel CC, M\u00fcller MA, Carbajo-Lozoya J, Stellberger T, von Dall\u2019Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Z\u00fcst R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-We\u00dfels C, P\u00f6hlmann S, Haas J, Drosten C, von Brunn A (2011) The SARS-Coronavirus-host interactome: identification of cyclophilins as target for pan-Coronavirus inhibitors. PLoS Pathog 7:e1002331. https:\/\/doi.org\/10.1371\/journal.ppat.1002331","journal-title":"PLoS Pathog"},{"key":"4880_CR66","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86318","volume":"2","author":"S Feske","year":"2001","unstructured":"Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A (2001) Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2:316\u2013324. https:\/\/doi.org\/10.1038\/86318","journal-title":"Nat Immunol"},{"key":"4880_CR67","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1101\/gad.1102703","volume":"17","author":"PG Hogan","year":"2003","unstructured":"Hogan PG, Chen L, Nardone J, Rao A (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205\u20132232. https:\/\/doi.org\/10.1101\/gad.1102703","journal-title":"Genes Dev"},{"key":"4880_CR68","doi-asserted-by":"publisher","unstructured":"Mousavizadeh L, Ghasemi S (2020) Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.022","DOI":"10.1016\/j.jmii.2020.03.022"},{"key":"4880_CR69","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J (2020) Coronavirus infections and immune responses. J Med Virol 92:424\u2013432","journal-title":"J Med Virol"},{"key":"4880_CR70","first-page":"174","volume":"28","author":"AA Rabaan","year":"2020","unstructured":"Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS et al (2020) SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Infez Med 28:174\u2013184","journal-title":"Infez Med"},{"key":"4880_CR71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4014\/jmb.2003.03011","volume":"30","author":"DG Ahn","year":"2020","unstructured":"Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 30:313\u2013324. https:\/\/doi.org\/10.4014\/jmb.2003.03011","journal-title":"J Microbiol Biotechnol"},{"key":"4880_CR72","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418\u2013423. https:\/\/doi.org\/10.1002\/jmv.25681","journal-title":"J Med Virol"},{"key":"4880_CR73","doi-asserted-by":"publisher","first-page":"e2107","DOI":"10.1002\/rmv.2107","volume":"30","author":"M Rokni","year":"2020","unstructured":"Rokni M, Ghasemi V, Tavakoli Z (2020) Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: comparison with SARS and MERS. Rev Med Virol 30:e2107. https:\/\/doi.org\/10.1002\/rmv.2107","journal-title":"Rev Med Virol"},{"key":"4880_CR74","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jinf.2020.02.010","volume":"80","author":"Q Han","year":"2020","unstructured":"Han Q, Lin Q, Jin S, You L (2020) Coronavirus 2019-nCoV: a brief perspective from the front line. J Inf Secur 80:373\u2013377. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.010","journal-title":"J Inf Secur"},{"issue":"26","key":"4880_CR75","doi-asserted-by":"publisher","first-page":"20112748","DOI":"10.1101\/2020.05.26.20112748","volume":"05","author":"L Malle","year":"2020","unstructured":"Malle L, Gao C, Bouvier N, Percha B (2020) Bogunovic D (2020)COVID-19 hospitalization is more frequent and severe in Down syndrome. MedRxiv 05(26):20112748. https:\/\/doi.org\/10.1101\/2020.05.26.20112748","journal-title":"MedRxiv"},{"key":"4880_CR76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ddrr.1128","volume":"18","author":"WB Zigman","year":"2013","unstructured":"Zigman WB (2013) Atypical aging in down syndrome. Dev Disabil Res Rev 18:51\u201367. https:\/\/doi.org\/10.1002\/ddrr.1128","journal-title":"Dev Disabil Res Rev"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-020-04880-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:40:42Z","timestamp":1611834042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-020-04880-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4880"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04880-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research is not involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}